Laddar...
Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
Epidermal growth factor inhibitors (EGFRI), the first targeted cancer therapy, are currently an essential treatment for many advance-stage epithelial cancers. These agents have the superior ability to target cancers cells and better safety profile compared to conventional chemotherapies. However, cu...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Hindawi Publishing Corporation
2014
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3958662/ https://ncbi.nlm.nih.gov/pubmed/24723942 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/734249 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|